Curix
PrivateLast Round
Grant
Feb 10, 2026
Company Overview
Curix is a medical technology company developing a drug delivery platform that uses a microbubble injector system and focused ultrasound to temporarily open the blood-brain barrier for treating neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Clinical Trials, Compliance & Risk, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curix Comparables
Compare Curix with similar companies based on industry and business-model similarity.
Curix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 10, 2026 | ||||
| Early Funding | Nov 21, 2023 |
Curix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Health Initiative | Grant |
| Stichting Twinning Participaties | Early Funding |
Curix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curix's valuation, stock price, and market status.